Sort by

Send to

Choose Destination

Links from PubMed

Items: 16


γ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current Status.

Singh VK, Hauer-Jensen M.

Int J Mol Sci. 2016 May 3;17(5). pii: E663. doi: 10.3390/ijms17050663. Review.


Vitamin E Analogs as Radiation Response Modifiers.

Singh PK, Krishnan S.

Evid Based Complement Alternat Med. 2015;2015:741301. doi: 10.1155/2015/741301. Epub 2015 Aug 20. Review.


Oxidative stress and lipid peroxidation products in cancer progression and therapy.

Barrera G.

ISRN Oncol. 2012;2012:137289. doi: 10.5402/2012/137289. Epub 2012 Oct 17.


Novel drugs to ameliorate gastrointestinal normal tissue radiation toxicity in clinical practice: what is emerging from the laboratory?

Berbée M, Hauer-Jensen M.

Curr Opin Support Palliat Care. 2012 Mar;6(1):54-9. doi: 10.1097/SPC.0b013e32834e3bd7. Review.


γ-Tocotrienol does not substantially protect DS neurons from hydrogen peroxide-induced oxidative injury.

Then SM, Sanfeliu C, Top GM, Wan Ngah WZ, Mazlan M.

Nutr Metab (Lond). 2012 Jan 5;9:1. doi: 10.1186/1743-7075-9-1.


γ-Tocotrienol protects against mitochondrial dysfunction and renal cell death.

Nowak G, Bakajsova D, Hayes C, Hauer-Jensen M, Compadre CM.

J Pharmacol Exp Ther. 2012 Feb;340(2):330-8. doi: 10.1124/jpet.111.186882. Epub 2011 Oct 31.


Tocotrienol vitamin E protects against preclinical canine ischemic stroke by inducing arteriogenesis.

Rink C, Christoforidis G, Khanna S, Peterson L, Patel Y, Khanna S, Abduljalil A, Irfanoglu O, Machiraju R, Bergdall VK, Sen CK.

J Cereb Blood Flow Metab. 2011 Nov;31(11):2218-30. doi: 10.1038/jcbfm.2011.85. Epub 2011 Jun 15.


Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E.

Viola V, Pilolli F, Piroddi M, Pierpaoli E, Orlando F, Provinciali M, Betti M, Mazzini F, Galli F.

Genes Nutr. 2012 Jan;7(1):29-41. doi: 10.1007/s12263-011-0219-9. Epub 2011 Apr 20.


γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent.

Rajendran P, Li F, Manu KA, Shanmugam MK, Loo SY, Kumar AP, Sethi G.

Br J Pharmacol. 2011 May;163(2):283-98. doi: 10.1111/j.1476-5381.2010.01187.x.


{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.

Kunnumakkara AB, Sung B, Ravindran J, Diagaradjane P, Deorukhkar A, Dey S, Koca C, Yadav VR, Tong Z, Gelovani JG, Guha S, Krishnan S, Aggarwal BB.

Cancer Res. 2010 Nov 1;70(21):8695-705. doi: 10.1158/0008-5472.CAN-10-2318. Epub 2010 Sep 23.


Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

Aggarwal BB, Sundaram C, Prasad S, Kannappan R.

Biochem Pharmacol. 2010 Dec 1;80(11):1613-31. doi: 10.1016/j.bcp.2010.07.043. Epub 2010 Aug 7. Review.


Mixed tocotrienols inhibit prostate carcinogenesis in TRAMP mice.

Barve A, Khor TO, Reuhl K, Reddy B, Newmark H, Kong AN.

Nutr Cancer. 2010;62(6):789-94. doi: 10.1080/01635581003605896.


Vitamin E delta-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration.

Husain K, Francois RA, Hutchinson SZ, Neuger AM, Lush R, Coppola D, Sebti S, Malafa MP.

Pharmacology. 2009;83(3):157-63. doi: 10.1159/000190792. Epub 2009 Jan 13.


Gamma-tocotrienol suppresses prostate cancer cell proliferation and invasion through multiple-signalling pathways.

Yap WN, Chang PN, Han HY, Lee DT, Ling MT, Wong YC, Yap YL.

Br J Cancer. 2008 Dec 2;99(11):1832-41. doi: 10.1038/sj.bjc.6604763. Epub 2008 Nov 11.


Tocotrienols: the emerging face of natural vitamin E.

Sen CK, Khanna S, Rink C, Roy S.

Vitam Horm. 2007;76:203-61. Review.


Tocotrienols in health and disease: the other half of the natural vitamin E family.

Sen CK, Khanna S, Roy S.

Mol Aspects Med. 2007 Oct-Dec;28(5-6):692-728. Epub 2007 Mar 27. Review.

Items per page

Supplemental Content

Write to the Help Desk